Drugs / CAR-T
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT06828341 | Jun → Jul 2024 | glioma | JIANG LONGWEI | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CAR-T | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06828341 ↗ |
| Modality | Cell therapy | “allogeneic CAR-T cells” NCT06828341 ↗ |
| Target | CD70 | “allogeneic CAR-T targeting CD70” NCT06828341 ↗ |